Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 4 2Phase 2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Recruiting 3Completed 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 2Tumor-Agnostic 1CNS 1

Conditions

Hemorrhage 2Hematologic Neoplasms 2Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 222Carboplatin 215Cisplatin 203Paclitaxel 181Gemcitabine 148Docetaxel 126Capecitabine 114Cyclophosphamide 102Pemetrexed 100Dexamethasone 100Specimen Handling 99Magnetic Resonance Spectroscopy 97Oxaliplatin 96Radiotherapy 94Doxorubicin 91Fluorouracil 88Bevacizumab 84Leucovorin 73Nivolumab 72Rituximab 71Vincristine 68durvalumab 65Lenalidomide 64Radiation 62atezolizumab 61Irinotecan 61Etoposide 60130-nm albumin-bound paclitaxel 58Prednisone 55Letrozole 55

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Tranexamic Acid × 1 year × Clear all
NCT06229483 2026-03-19

The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies

Nova Scotia Health Authority

Phase 3 Recruiting
102 enrolled
CNS

Brain Neoplasms, Hemorrhage

NCT05053867 2026-01-14

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Recruiting
60 enrolled
Tumor-Agnostic

Neoplasms

NCT04448184 2026-01-08

PATH

Ottawa Hospital Research Institute

Phase 3 Recruiting
662 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT03136445 2025-10-28

TREATT

NHS Blood and Transplant

Phase 3 Completed
616 enrolled 34 charts
Other hematologic neoplasm

Hemorrhage, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡